COMP <GO>
ZBH vs ISRG // NET PROFIT MARGIN
Zimmer Biomet Holdings Inc. (NYSE) VS. Intuitive Surgical Inc. (NASDAQ) • 15-METRIC TALLY: ZBH 6
— ISRG 8
▲ NET PROFIT MARGIN LEADER: ISRG
LAST: $94.52 (-3.03%) • MKT CAP: $18.59B
net-margins
8.60%
LAST: $432.01 (-3.73%) • MKT CAP: $155.56B
net-margins
28.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZBH VS. ISRG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZBH | ISRG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.70% | 66.00% | +3.70 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 15.00% | -10.40 | ISRG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.3x | 46.0x | -26.70 | ZBH | /valuation <GO> |
| Free Cash Flow Yield | 7.92% | 1.66% | +6.26 | ZBH | /fcf-yield <GO> |
| Operating Margin | 13.30% | 29.30% | -16.00 | ISRG | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 8.60% | 28.40% | -19.80 | ISRG | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 20.50% | -13.30 | ISRG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 0.00% | +1.02 | ZBH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.42 | 26.00 | -23.58 | ISRG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | ISRG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 61.7 | -4.70 | ISRG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.97 | +0.05 | ZBH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.6x | 45.8x | -21.20 | ZBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.59B | $155.56B | -$136.97B | ISRG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZBH REV | ISRG REV | ZBH GROSS % | ISRG GROSS % | ZBH FCF | ISRG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.23B | $10.06B | 69.7% | 66.0% | $1.47B | $2.58B |
| FY 2024 | $7.68B | $8.35B | 71.5% | 67.5% | $1.30B | $2.04B |
| FY 2023 | $7.39B | $7.12B | — | — | $1.25B | $1.49B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZBH // BETA 1.02
ISRG // BETA 0.97